Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 08, 2019

SELL
$27.94 - $44.61 $1.98 Million - $3.16 Million
-70,902 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$38.6 - $46.12 $77 - $92
2 Added 0.0%
70,902 $3.01 Million
Q1 2018

May 15, 2018

SELL
$53.61 - $67.26 $1.45 Million - $1.82 Million
-27,000 Reduced 27.58%
70,900 $4.11 Million
Q4 2017

Feb 14, 2018

BUY
$47.69 - $55.39 $4.67 Million - $5.42 Million
97,900
97,900 $5.36 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.55B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Gam Holding Ag Portfolio

Follow Gam Holding Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on Gam Holding Ag with notifications on news.